Most Surveyed Clinicians Will Prescribe Amgen/GlaxoSmithKline’s…

Main Category: Bones / Orthopaedics Also Included In: Pharmacy / Pharmacist Article Date: 04 Dec 2009 Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the majority of surveyed clinicians say they will use Amgen/GlaxoSmithKline’s Prolia as either a second- or third-line …

source : www.topix.com

Related News:

• ‘World’s Most Useful Tree’ Provides Low-Cost Water Purification Method For Developing World
• Don’t Miss The Opportunity To Attend The Most Exciting Bone Meeting In The Asia-Pacific Region In 2010
• Potential Therapeutic Target For Most Common Solid Cancer In Childhood
• AAPM: Most Chronic Opioid Users Likely Nonadherent (CME/CE, with video)
• For-Profit Hospitals Most Likely to Overtreat Dementia Patients (CME/CE, with video)
• Most Adults Are Not Getting Necessary Vaccinations
• No Need for Most Moms to Fast During Labor (CME/CE)
• Gastric Bypass Extends Life for Most Patients (CME/CE)
• Most MDs Delay End-of-Life Talks (CME/CE)
• Most Plentiful Cell Type In The HeartThe Fibroblast -contributes To Heart Failure